Societe L'oreal Sa

Catherine Gerst

Maria Dalko

Jean-Baptiste Galey

Bruno Bernard

Francis Pruche

Patrick Pichaud

Lionel Breton

Jean-Francedillaois Nadaud

Pierre Tachon

The invention relates to the use, as active principle, in a physiologically acceptable medium, in a composition, of an effective amount of at least one compound of the indolecarboxylic family, this compound or these compositions being intended to treat disorders associated with overactivity of 5&agr;-reductase. These compounds or the compositions containing them are more particularly intended to treat androgen-dependent disorders such as, for example, seborrhoea and/or acne and/or hirsutism and/or androgenic alopecia. The invention also relates to novel compounds of the indolecarboxylic family and to compositions-containing them.

Compounds of the indolecarboxylic family and use thereof

The invention relates to the use, as active principle, in a physiologically acceptable medium, in a composition, of an effective amount of at least one compound of the indolecarboxylic family, this compound or these compositions being intended to treat disorders associated with overactivity of &agr;-reductase. These compounds or the compositions containing them are more particularly intended to treat androgen-dependent disorders such as seborrhoea and/or acne and/or hirsutism and/or androgenic alopecia. The invention also relates to novel compounds of the indolecarboxylic family and to compositions containing them.

Indolecarboxylic compounds and their use as pharmaceutical compounds

6-substituted pyrimidine 3-oxides for promoting pigmentation of the skin/hair

Topically applicable dermocosmetic compositions for improving or maintaining the appearance of human skin or the scalp, comprise a minor antioxidant effective amount of melatonin or analog thereof, formulated into a topically applicable, cosmetically/dermatologically acceptable vehicle, diluent or carrier therefor, such minor antioxidant effective amount being less than 10.sup.-4 % by weight relative to the total weight thereof, e.g., no greater than 0.5.times.10.sup.-4 % or ranging from 10.sup.-12 % to 10.sup.-15 % by weight thereof.

Antioxidative dermocosmetic compositions comprising very low dosages of

Growing community of inventors

Asnieres/Seine, France

Catherine Gerst